SGMO Historical Earnings image   This SGMO historical earnings page last updated 5/9/2022
SGMO Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20225/5/20220.03B
Q4 20212/24/20220.03B
Q3 202111/4/20210.03B
Q2 20218/5/20210.03B
Q1 20215/4/20210.03B
Q4 20202/24/20210.03B
Q3 202011/4/20200.06B
Q2 20208/5/20200.02B
Q1 20205/11/20200.01B
Q4 20192/28/20200.05B
Q3 201911/6/20190.02B
Q2 20198/7/20190.02B
Q1 20195/8/20190.01B
Q4 20182/28/201926.84M
Q3 201811/8/201823.56M
Q2 20188/8/201821.42M
Q1 20185/8/201812.64M
Q4 20172/22/201813.08M
Q3 201711/9/201711.81M
Q2 20178/9/20178.25M
Q1 20175/10/20173.42M
Q4 20162/28/20178.92M
Q3 201610/26/20162.82M
Q2 20168/3/20163.70M
Q1 20165/2/20163.94M
Q4 20152/9/20169.12M
Q3 201510/28/20158.57M
Q2 20158/5/20158.36M
Q1 20154/22/201513.49M
Q4 20142/10/201514.95M
Q3 201410/22/201412.40M
Q2 20147/23/201410.40M
Q1 20145/6/20148.12M
Q4 20132/11/20146.87M
Q3 201310/23/20135.71M
Q2 20137/24/20136.93M
Q1 20135/8/20134.62M
Q4 20122/6/20138.90M
Q3 201210/24/20124.90M
Q2 20127/25/20124.57M
Q1 20125/2/20123.24M
SGMO Historical Earnings EPS
Data adjusted for SGMO split history

PeriodHistorical Earnings DateGAAP
Q1 20225/5/2022-0.300
Q4 20212/24/2022-0.260
Q3 202111/4/2021-0.330
Q2 20218/5/2021-0.330
Q1 20215/4/2021-0.320
Q4 20202/24/2021-0.290
Q3 202011/4/2020-0.010
Q2 20208/5/2020-0.260
Q1 20205/11/2020-0.370
Q4 20192/28/20200.040
Q3 201911/6/2019-0.240
Q2 20198/7/2019-0.260
Q1 20195/8/2019-0.410
Q4 20182/28/2019-0.18
Q3 201811/8/2018-0.13
Q2 20188/8/2018-0.17
Q1 20185/8/2018-0.23
Q4 20172/22/2018-0.15
Q3 201711/9/2017-0.15
Q2 20178/9/2017-0.17
Q1 20175/10/2017-0.23
Q4 20162/28/2017-0.14
Q3 201610/26/2016-0.27
Q2 20168/3/2016-0.38
Q1 20165/2/2016-0.23
Q4 20152/9/2016-0.2
Q3 201510/28/2015-0.13
Q2 20158/5/2015-0.17
Q1 20154/22/2015-0.08
Q4 20142/10/2015-0.06
Q3 201410/22/2014-0.11
Q2 20147/23/2014-0.1
Q1 20145/6/2014-0.12
Q4 20132/11/2014-0.13
Q3 201310/23/2013-0.11
Q2 20137/24/2013-0.1
Q1 20135/8/2013-0.13
Q4 20122/6/2013-0.07
Q3 201210/24/2012-0.11
Q2 20127/25/2012-0.11
Q1 20125/2/2012-0.14
Quotes delayed 20 minutes

Email EnvelopeFree SGMO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Sangamo Therapeutics (SGMO) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SGRY Past Earnings
SGTX Past Earnings
SHC Past Earnings
SIBN Past Earnings
SIEN Past Earnings
SIGA Past Earnings
SILK Past Earnings
SINT Past Earnings
SIOX Past Earnings
SLDB Past Earnings
What was the record high SGMO historical earnings result?
In terms of earnings or revenue, what is the best SGMO historical earnings result that Sangamo Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest SGMO historical earnings result was set in Q4 2019, when Sangamo Therapeutics posted results of 0.040/share. The most successful revenue quarter within our data set was Q3 2020 when Sangamo Therapeutics reported revenue of 0.06B.

What was the lowest Sangamo Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest SGMO has reported, and when?

✔️Accepted answer: Within our data set, the lowest SGMO historical earnings result was set in Q1 2019, when Sangamo Therapeutics posted results of -0.410/share. The smallest revenue quarter within our data set was Q3 2016 when Sangamo Therapeutics reported revenue of 2.82M.

On this page we presented the SGMO historical earnings date information for Sangamo Therapeutics. Reviewing that SGMO Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2019, when SGMO posted gaap of 0.040/share. Meanwhile the lowest SGMO historical earnings result was in Q1 2019, when SGMO posted gaap of -0.410/share. Moving to Sangamo Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2020 when SGMO reported 0.06B in revenue, while the smallest revenue quarter was Q3 2016 when SGMO reported 2.82M in revenue.

For self directed investors doing their due diligence on SGMO or any other given stock, their research can benefit from looking into all of the Sangamo Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Sangamo Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for SGMO. Thanks for visiting, and the next time you need to research SGMO historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: MGEE Price Target, SWRM Options Chain, OUST shares outstanding history.

 

SGMO Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.